InsiderTrades

Form 4 for CDLX Cardlytics, Inc.

Accepted 2025-01-06 00:00:00 ET · period of report 2025-01-01 · accession 0001666071-25-000002 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-01-06 2025-01-01 CDLX Gupta Amit CEO, Dir M - OptEx — +14.3K 192.9K +8% —
D 2025-01-06 2025-01-03 CDLX Gupta Amit CEO, Dir S - Sale+OE $3.67 -5,964 186.9K -3% -$21.9K
D 2025-01-06 2025-01-01 CDLX Gupta Amit CEO, Dir M - OptEx $0.00 -14.3K 71.7K -17% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-01-01 M A 14,349 — 192,868 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.
2 Common Common Stock 2025-01-03 S D 5,964 $3.67 186,904 D — — (F2) Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on January 1, 2025. The Reporting Person did not sell shares for any other purpose. (F3) The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $3.555 to $3.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).
3 Derivative Restricted Stock Units 2025-01-01 M D 14,349 $0.00 71,748 D — · — to — 14,349 Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. (F4) The RSU award was originally for 114,796 shares. The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date.